R-CHMP regimen

Jump to navigation Jump to search

WikiDoc Resources for R-CHMP regimen

Articles

Most recent articles on R-CHMP regimen

Most cited articles on R-CHMP regimen

Review articles on R-CHMP regimen

Articles on R-CHMP regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on R-CHMP regimen

Images of R-CHMP regimen

Photos of R-CHMP regimen

Podcasts & MP3s on R-CHMP regimen

Videos on R-CHMP regimen

Evidence Based Medicine

Cochrane Collaboration on R-CHMP regimen

Bandolier on R-CHMP regimen

TRIP on R-CHMP regimen

Clinical Trials

Ongoing Trials on R-CHMP regimen at Clinical Trials.gov

Trial results on R-CHMP regimen

Clinical Trials on R-CHMP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on R-CHMP regimen

NICE Guidance on R-CHMP regimen

NHS PRODIGY Guidance

FDA on R-CHMP regimen

CDC on R-CHMP regimen

Books

Books on R-CHMP regimen

News

R-CHMP regimen in the news

Be alerted to news on R-CHMP regimen

News trends on R-CHMP regimen

Commentary

Blogs on R-CHMP regimen

Definitions

Definitions of R-CHMP regimen

Patient Resources / Community

Patient resources on R-CHMP regimen

Discussion groups on R-CHMP regimen

Patient Handouts on R-CHMP regimen

Directions to Hospitals Treating R-CHMP regimen

Risk calculators and risk factors for R-CHMP regimen

Healthcare Provider Resources

Symptoms of R-CHMP regimen

Causes & Risk Factors for R-CHMP regimen

Diagnostic studies for R-CHMP regimen

Treatment of R-CHMP regimen

Continuing Medical Education (CME)

CME Programs on R-CHMP regimen

International

R-CHMP regimen en Espanol

R-CHMP regimen en Francais

Business

R-CHMP regimen in the Marketplace

Patents on R-CHMP regimen

Experimental / Informatics

List of terms related to R-CHMP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Marqibo-Prednisone regimen

Overview

R-CHMP regimen refers to a regimen consisting of rituximab, cyclophosphamide , doxorubicin (hydroxydaunorubicin), vincristine (Marqibo), and prednisone used to treat aggressive non-Hodgkin's lymphoma.[1]

Regimen

RRituximab (Rituxan)

CCyclophosphamide (Cytoxan)

HDoxorubicin (Hydroxydaunorubicin)

MVincristine liposomal (Marqibo)

PPrednisone

Indications

References

  1. 1.0 1.1 Hagemeister F, Rodriguez MA, Deitcher SR, Younes A, Fayad L, Goy A; et al. (2013). "Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas". Br J Haematol. 162 (5): 631–8. doi:10.1111/bjh.12446. PMID 23802738.